Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Ocena Skuteczności Pielęgnacji Skóry Głowy dla Eliksiru Odmładzającego Premium

9 listopada 2026 zaktualizowane przez: Tsong-Min Chang, Hungkuang University

Ocena Efektów Pielęgnacyjnych Eliksiru Odmładzającego Premium na Skórę Głowy

The study aims to evaluate the efficacy of the Premium Revitalizing Elixir on human scalp skin. A total of 60 healthy adults, aged 18 to 60 with alopecia, baldness, or self-identified with symptoms of hair thinning will be recruited and randomly assigned into five groups receiving different formulations. Participants will use the product once daily for 56 days, and their scalp conditions will be assessed through skin texture tests at multiple time points. Key parameters such as sebum content, overall hair loss, hair density, scalp condition, and hair length will be measured. A self-assessment and assessment by a hair specialist on hair and scalp condition will also be provided at the end of the study (Day 56).

Przegląd badań

Szczegółowy opis

This is a prospective, randomized, double-blinded, and placebo-controlled study to investigate the effects of Premium Scalp Revitalizing Essence on changes in the skin texture of human scalp skin.

This study aims to enroll 60 healthy adults aged from 18 to 60 with alopecia, baldness, or self-identified with symptoms of hair thinning.

Inclusion criteria include healthy adults defined as individuals without chronic diseases, significant illnesses (including cancer, post-stroke disorders, paralysis, acute myocardial infarction, coronary artery bypass surgery, end-stage renal disease, and major organ transplant or hematopoietic stem cell transplant), or allergic constitutions, and who are not currently taking any medication or using any scalp care products.

Exclusion criteria include individuals who are pregnant or breastfeeding, as well as males or females with chronic diseases, significant illnesses, or allergic constitutions, currently using scalp care products, students or employees affiliated with the principal investigator, individuals with scalp wounds, those who have participated in cosmetic product testing, and those who have undergone scalp aesthetic treatments within the past three months.

The participants will be randomly assigned into five groups, with 12 individuals in each group. Group 1 uses Placebo (Base formula without caffeine and panthenol); Group 2 uses the Base formula (Control with 0.1% caffeine and panthenol); Group 3 uses Base + IGF-1 & FGF-7; Group 4 uses Base + Centella asiatica extracellular vesicles + Ginger-derived extracellular vesicles; Group 5 uses Base + Centella asiatica extracellular vesicles + Ginger-derived extracellular vesicles + IGF-1 & FGF-7 (each growth factor at twice the concentration than that in Group 3). Before using the test product, all 60 participants undergo the first scalp skin texture test. After 14 days of using the test product, a second scalp skin texture test is conducted; after 28 days of use, a third test is performed; after 42 days of use, a fourth test is conducted; and after 56 days of use, a fifth test is carried out. The scalp skin texture tests include measurements of skin (1) sebum content, (2) overall hair loss, (3) hair density, (4) scalp condition, (5) hair length, and other parameters. The Sebumeter® SM815 probe of the MPA580 device and the ScalpX Intelligent Scalp Diagnostic System will be used to measure the parameters of the study. On Day 56, the participants will be asked to fill out a self-assessment form and a hair specialist will also assess the hair and scalp condition at the end of the study.

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

60

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

      • Taichung, Tajwan, 433304
        • Hungkuang University

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat do 60 lat (Dorosły)

Akceptuje zdrowych ochotników

Tak

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  • Healthy adults of any gender from the age of 18 to 60 years (inclusive).
  • Having symptoms of alopecia, baldness, or self-identified with hair thinning.
  • Absence of chronic diseases, major illnesses, or allergies.
  • Major illnesses include cancer, post-stroke disorders, paralysis, acute myocardial infarction, coronary artery bypass surgery, end-stage renal disease, and major organ transplant or hematopoietic stem cell transplant

Exclusion Criteria:

  • Currently taking any medication or using any scalp care products
  • Pregnant or breastfeeding
  • Chronic diseases, significant illnesses, or allergic constitutions
  • Currently using scalp care products
  • Students or employees affiliated with the principal investigator,
  • Individuals with scalp wounds
  • Participated in cosmetic product testing
  • Undergone scalp aesthetic treatments within the past three months.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Potroić

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Komparator placebo: Group 1: Placebo control

Base formula without caffeine and panthenol

Placebo control (base formula without caffeine and panthenol). Applied 1mL evenly to the scalp once daily after hair wash for 56 consecutive days.

Eksperymentalny: Group 2: Base formula only

Base formula consisting of active ingredients 0.1% caffeine and panthenol (vitamin B5).

Base formula consisting of active ingredients 0.1% caffeine and panthenol. Applied 1mL evenly to the scalp once daily after hair wash for 56 consecutive days.

Eksperymentalny: Group 3: Base formula plus IGF-1 & FGF-7.

Base formula plus insulin growth factor-1 (IGF-1, 250 ng/mL) and fibroblast growth factor-7 (FGF-7, 150 ng/mL)

Base formula plus insulin growth factor-1 (IGF-1, 250 ng/mL) and fibroblast growth factor-7 (FGF-7, 150 ng/mL). Applied 1mL evenly to the scalp once daily after hair wash for 56 consecutive days.

Eksperymentalny: Group 4: Base formula plus Centella asiatica and ginger extracellular vesicles

Base formula plus Centella asiatica and ginger (Zingiber officinale) extracellular vesicles (1E9 particles/mL)

Base formula plus Centella asiatica and ginger extracellular vesicles (1E9 particles/mL). Applied 1mL evenly to the scalp once daily after hair wash for 56 consecutive days.

Eksperymentalny: Group 5: Base formula plus Centella asiatica and ginger extracellular vesicles, IGF-1 & FGF-7.

Base formula plus Centella asiatica and ginger (Zingiber officinale) extracellular vesicles (both 1E9 particles/mL), insulin growth factor-1 (IGF-1, 500 ng/mL) and fibroblast growth factor-7 (FGF-7, 300 ng/mL)

Base formula plus Centella asiatica and ginger extracellular vesicles (both 1E9 particles/mL), insulin growth factor-1 (IGF-1, 500 ng/mL) and fibroblast growth factor-7 (FGF-7, 300 ng/mL). Applied 1mL evenly to the scalp once daily after hair wash for 56 consecutive days.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Sebum Content
Ramy czasowe: Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0 as baseline)

Assess oil levels on the scalp at standardized scalp sites (left, right, and vertex). Measured with C+K Multi Probe Adaptor MPA580 system using the Sebumeter® SM815 probe based on the grease spot photometry method with the sebum measurement cassette tape.

Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0 as baseline)
Hair length
Ramy czasowe: Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0 as baseline)

Hair length (cm): Measured manually with ruler at standardized scalp sites (left, right, and vertex).

Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0 as baseline)
Hair density
Ramy czasowe: Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0 as baseline)

Hair density (number of hairs/cm-square): Assessed with the ScalpX Intelligent Scalp Diagnostic System with digital microscopy at standardized scalp sites (left, right, and vertex).

Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0 as baseline)
Hair thickness
Ramy czasowe: Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0 as baseline)

Hair thickness (micrometers): Assessed with the ScalpX Intelligent Scalp Diagnostic System with digital microscopy at standardized scalp sites (left, right, and vertex).

Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0 as baseline)
Hair loss
Ramy czasowe: Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0)

Hair loss: Assessed by the standardized hair combing test by counting the number of hairs shed after the participants' hair was combed over a clean surface for 60 strokes.

Assessment conducted every 14 days from Day 0 to Day 56 (including Day 0)

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Participant self-assessment
Ramy czasowe: Day 56 (End of the study period)

Participants will be asked to fill out an assessment form with score from 0 to 4 for each of the hair and scalp condition evaluated.

Day 56 (End of the study period)
Hair specialist assessment
Ramy czasowe: Day 56 (End of the study)

A hair specialist will assess the hair and scalp condition of the participant and assign a score from 0 to 4 for each of the evaluated items as well as assign a score of Global Aesthetic Improvement Scale (GAIS) from -1 to 3.

Day 56 (End of the study)

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

1 listopada 2025

Zakończenie podstawowe (Rzeczywisty)

31 maja 2026

Ukończenie studiów (Rzeczywisty)

31 maja 2026

Daty rejestracji na studia

Pierwszy przesłany

27 listopada 2025

Pierwszy przesłany, który spełnia kryteria kontroli jakości

27 listopada 2025

Pierwszy wysłany (Rzeczywisty)

9 grudnia 2025

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

12 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

9 listopada 2026

Ostatnia weryfikacja

1 listopada 2026

Więcej informacji

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj